For example, in a mouse melanoma model, therapeutic efficacy of high-doses of intratumoral IFN-α/β appears not to be T cell dependent, but rather relies on their anti-angiogenic properties, acting directly on the tumor vasculature [127]. Here, IFNA1 is linked to melanoma.